Please assess the completion status of the following clinical trial:

Trial Title: Kidney Damage In Patients With Severe Fall In eGFR

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provides written Informed Consent~* Is at least 18 years of age;~* Is scheduled for or likely to undergo percutaneous coronary intervention;~* Has documented estimated glomerular filtration rate \[eGFR\] \< 30 mL/min/1.73 m2 calculated with the MDRD formula within 72 hours prior the enrolment.~Exclusion Criteria:~* Is a pregnant or lactating female~* Has a history of severe congestive heart failure~* Has a history of hyperthyroidism~* Has unstable renal function~* Has a history of hypersensitivity to iodinated contrast agents

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IOPAMIDOL injection 370 (Type: ACTIVE_COMPARATOR): None
- Iodixanol 320 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).